Neuropeptides as Autocrine Growth Factors in Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
495-509
Author(s):
Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen
Retinoic Acid Metabolism and Mechanism of Action: A Review
Journal:
Current Drug Metabolism
Volume:
4
Page:
1-10
Author(s):
Julie Marill, Nadia Idres, Claude C. Capron, Eric Nguyen and Guy G. Chabot
DNA Demethylating Agents and Chromatin-Remodelling Drugs: Which, How and Why?
Journal:
Current Drug Metabolism
Volume:
4
Page:
22-31
Author(s):
Ana Villar-Garea and Manel Esteller
Drug Metabolism and Individualized Medicine
Journal:
Current Drug Metabolism
Volume:
4
Page:
33-44
Author(s):
Pratima Srivastava
Cancer and Phase II Drug-Metabolizing Enzymes
Journal:
Current Drug Metabolism
Volume:
4
Page:
45-58
Author(s):
S. A. Sheweita and A. K. Tilmisany
subject Index To Volume 3
Journal:
Current Drug Metabolism
Volume:
4
Page:
87-90
Author(s):
Bentham Science Publishers
Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
1-19
Author(s):
R. Z. Yusuf, Z. Duan, D. E. Lamendola, R. T. Penson and M. V. Seiden
Mechanisms Controlling Sensitivity to Platinum Complexes: Role of p53 and DNA Mismatch Repair
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
21-29
Author(s):
S. Manic, L. Gatti, N. Carenini, G. Fumagalli, F. Zunino and P. Perego
Oncogenic Signaling Pathways Activated by RON Receptor Tyrosine Kinase
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
31-40
Author(s):
Alla Danilkovitch-Miagkova
Molecular Targets of the Oncogenic Transcription Factor Jun
Journal:
Current Cancer Drug Targets
Volume:
3
Page:
41-55
Author(s):
M. Hartl, A. G. Bader and K. Bister